JPX Equity Snapshot
4569 Weekly Equity Report
KYORIN Pharmaceutical Co., Ltd.
What the company does
KYORIN Pharmaceutical Co., Ltd., through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally. The company offers Flutiform, a drug for the treatment of asthma; Lyfuna for cough treatment; Desalex, an antiallergic agent; Beova, and Uritos KYORIN therapeutic agents for overactive bladder; Lasvic, a quinolone synthetic antibacterial agent; Pentasa, a remedy for ulcerative colitis/Crohn's disease; Nasonex and Mometasone KYORIN, which are used as allergic rhinitis therapeutic agents; and Kipres, a leukotriene receptor antagonist anti-bronchial asthma and allergic rhinitis drug. It also provides Mucodyne, a mucoregulating drug; GeneSoC, a …
What the weekly tape is saying
4569 closed the latest completed week at 1,150 JPY. The 4-week return is -19.0% and the 12-week return is -28.0%. Trend Signal is inactive, Market Dynamics is -1.02. Setup signature: Risk-first tape with a 21/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1,523 JPY
- Vs Trend Line
- -24.5%
- Fair Value
- 1,519 JPY
- Vs Fair Value
- -24.3%
- 52W High
- 1,724 JPY
- 52W Low
- 1,123 JPY
- Drawdown
- -33.3%
- Range Position
- 4.5%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 34
- 52W Active Breadth
- 65.4%
- Sector Scope
- JP Healthcare
- Sector Rank
- 76 of 223
- Sector Percentile
- 66.2%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
JP Healthcare
- Tracked Peers
- 100
- 4W Rank
- 93 of 100
- Avg 1W
- -1.3%
- Avg 4W
- -3.4%
- Trend Breadth
- 27.0%
- Positive MD
- 28.0%
JP Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 31
- 4W Rank
- 25 of 31
- Avg 1W
- -1.8%
- Avg 4W
- -10.9%
- Trend Breadth
- 9.7%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.02
- 4W MD Change
- -15.2%
- Relative Strength
- -41.64
- 4W RS Change
- -59.0%
- Expectation
- Undecided
- Probability
- 51.79%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 991.1K
- 13W Average
- 821.0K
- 52W Average
- 597.3K
- Vs 13W
- 1.2x
- Vs 52W
- 1.7x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.9%
- 52W Volatility
- 2.9%
- Upside Weeks
- 27
- Downside Weeks
- 23
- Downside Breadth
- 44.2%
- Avg Gain / Loss
- 1.8% / -2.9%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- JPX
- Country
- JP
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- JPY
- Market Cap
- 72.7B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1,150 JPY | 0.0% | 1,523 JPY | 1,519 JPY | -1.02 | -41.64 | 991.1K | Off |
| 5 Jun 2026 | 1,150 JPY | -9.2% | 1,530 JPY | 1,522 JPY | -0.93 | -42.89 | 1.4M | Off |
| 29 May 2026 | 1,266 JPY | -6.5% | 1,538 JPY | 1,524 JPY | -0.97 | -37.71 | 1.4M | Off |
| 22 May 2026 | 1,354 JPY | -4.6% | 1,542 JPY | 1,527 JPY | -0.96 | -31.07 | 1.6M | Off |
| 15 May 2026 | 1,420 JPY | -8.4% | 1,543 JPY | 1,528 JPY | -0.88 | -26.19 | 1.6M | Off |
| 8 May 2026 | 1,550 JPY | 1.5% | 1,543 JPY | 1,529 JPY | -0.77 | -21.78 | 315.6K | On |
| 1 May 2026 | 1,527 JPY | -3.4% | 1,538 JPY | 1,529 JPY | -0.44 | -19.47 | 522.3K | On |
| 24 Apr 2026 | 1,580 JPY | -3.7% | 1,534 JPY | 1,529 JPY | -0.03 | -17.62 | 496.1K | On |
| 17 Apr 2026 | 1,641 JPY | -1.0% | 1,531 JPY | 1,529 JPY | 0.32 | -13.32 | 340.0K | On |
| 10 Apr 2026 | 1,657 JPY | -2.2% | 1,525 JPY | 1,529 JPY | 0.42 | -10.77 | 463.4K | On |
| 3 Apr 2026 | 1,695 JPY | 3.1% | 1,520 JPY | 1,528 JPY | 0.47 | -2.86 | 499.3K | On |
| 27 Mar 2026 | 1,644 JPY | 2.9% | 1,513 JPY | 1,527 JPY | 0.55 | -6.72 | 690.5K | On |
| 20 Mar 2026 | 1,597 JPY | 0.6% | 1,507 JPY | 1,527 JPY | 0.64 | -9.89 | 306.1K | On |
| 13 Mar 2026 | 1,587 JPY | -2.2% | 1,504 JPY | 1,526 JPY | 0.93 | -11.69 | 501.0K | On |